OBI PHARMA, INC.
25Patents
25Active
25Granted
47Portfolio score
Filing activity: Jan 6, 2014 → Jan 27, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10815307B2 | Antibodies, pharmaceutical compositions and uses thereof | Physics | 5 | Active |
| US10935544B2 | Glycan arrays and method of use | Physics | 2 | Active |
| US9902779B2 | Antibodies, pharmaceutical compositions and uses thereof | Physics | 2 | Active |
| US11000601B2 | Conjugated biological molecules, pharmaceutical compositions and methods | Chemistry; Metallurgy | 1 | Active |
| US11642400B2 | Immunogenic/therapeutic glycan compositions and uses thereof | Human Necessities | 1 | Active |
| US11643456B2 | Human antibodies, pharmaceutical compositions and methods | Physics | 1 | Active |
| US11583577B2 | Cancer immunotherapy by immune activation or immune modulation via Globo series antigens | Physics | 1 | Active |
| US11203645B2 | Glycosynthase variants for glycoprotein engineering and methods of use | Physics | 1 | Active |
| US12053514B2 | Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatment | Human Necessities | 0 | Active |
| US10980894B2 | Antibodies, pharmaceutical compositions and methods | Chemistry; Metallurgy | 0 | Active |
| US11773118B2 | Methods of making high enantioselective secondary alcohols | Chemistry; Metallurgy | 0 | Active |
| US11833223B2 | Antibodies, pharmaceutical compositions and methods | Chemistry; Metallurgy | 0 | Active |
| US10517936B2 | Vaccines with higher carbohydrate antigen density and novel saponin adjuvant | Human Necessities | 0 | Active |
| US10829437B2 | Nitrobenzyl derivatives of anti-cancer agents | Human Necessities | 0 | Active |
| US10364261B2 | DNA alkylating agents | Physics | 0 | Active |
| US11752204B2 | Vaccines with higher carbohydrate antigen density and novel saponin adjuvant | Human Necessities | 0 | Active |
| US12234266B2 | CRM197 protein expression | Chemistry; Metallurgy | 0 | Active |
| US11535585B2 | Nitrobenzyl derivatives of anti-cancer agents | Human Necessities | 0 | Active |
| US12221461B2 | Saponin adjuvant and evaluation method thereof | Physics | 0 | Active |
| US10501532B2 | Carbohydrate antibodies, pharmaceutical compositions and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11041017B2 | Antibodies, pharmaceutical compositions and methods | Physics | 0 | Active |
| US12090212B2 | Conjugated biological molecules, pharmaceutical compositions and methods | Chemistry; Metallurgy | 0 | Active |
| US11236154B2 | Carbohydrate antibodies, pharmaceutical compositions and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US10766914B2 | DNA alkylating agents | Physics | 0 | Active |
| US10409869B2 | (R)- and (S)-1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-N,N'-bis (ethylene)phosphoramidate, compositions and methods for their use and preparation | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.